513 results on '"Jha, Manish K"'
Search Results
102. Social construction of migrant identities: everyday life of Bangladeshi migrants in West Bengal.
103. Can We Address the Shortage of Psychiatrists in the Correctional Setting with Exposure During Residency Training?
104. Vortioxetine Versus Placebo for Major Depressive Disorder
105. sj-docx-1-jop-10.1177_0269881120985147 – Supplemental material for Role of nitric oxide signaling in the antidepressant mechanism of action of ketamine: A randomized controlled trial
106. sj-docx-2-jop-10.1177_0269881120985147 – Supplemental material for Role of nitric oxide signaling in the antidepressant mechanism of action of ketamine: A randomized controlled trial
107. Improvements in irritability with sertraline versus placebo: Findings from the EMBARC study
108. Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial
109. Neuroimaging correlates and predictors of response to repeated-dose intravenous ketamine in PTSD: preliminary evidence
110. Cross-Sectional Associations Among Symptoms of Pain, Irritability, and Depression and How These Symptoms Relate to Social Functioning and Quality of Life
111. Social construction of migrant identities: everyday life of Bangladeshi migrants in West Bengal
112. Risks and resilience: COVID-19 response and disaster management policies in India
113. A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder
114. Role of nitric oxide signaling in the antidepressant mechanism of action of ketamine: A randomized controlled trial
115. Social Policy and State–Community Relationships: Storm over Forest Rights in India
116. Effect of Adjunctive Pimavanserin on Sleep/Wakefulness in Patients With Major Depressive Disorder
117. 'Stateless' Rohingyas: persecution, displacement and complex community development.
118. ‘Stateless’ Rohingyas: persecution, displacement and complex community development
119. What to Expect When Switching to a Second Antidepressant Medication Following an Ineffective Initial SSRI
120. Pharmacological Treatments for Patients with Treatment-Resistant Depression
121. Social Policy, COVID-19 and Impoverished Migrants: Challenges and Prospects in Locked Down India
122. Psychometric Properties of the Concise Associated Symptom Tracking Scale and Validation of Clinical Utility in the EMBARC Study
123. Efficacy of Esketamine Augmentation in Major Depressive Disorder
124. Improvement of sexual functioning during treatment of MDD with adjunctive pimavanserin: A secondary analysis
125. Cortical Connectivity Moderators of Antidepressant vs Placebo Treatment Response in Major Depressive Disorder
126. 180 Improvement of Sexual Function Observed During Treatment of Major Depressive Disorder with Adjunctive Pimavanserin
127. Anger attacks are associated with persistently elevated irritability in MDD: findings from the EMBARC study
128. Effect of Intrinsic Patterns of Functional Brain Connectivity in Moderating Antidepressant Treatment Response in Major Depression
129. Higher S100B Levels Predict Persistently Elevated Anhedonia with Escitalopram Monotherapy Versus Antidepressant Combinations: Findings from CO-MED Trial
130. Choosing Between Ketamine and Electroconvulsive Therapy for Outpatients With Treatment-Resistant Depression—Advantage Ketamine?
131. Validating pre-treatment body mass index as moderator of antidepressant treatment outcomes: Findings from CO-MED trial
132. Formalization, Citizenship and the Challenges of Self‐Governance in Mumbai's Slum Relocation Colonies.
133. Anger attacks are associated with persistently elevated irritability in MDD: findings from the EMBARC study.
134. Connectivity seeded in the dorsolateral prefrontal and subcallosal cingulate cortices is associated with antidepressant response in Major Depressive Disorder
135. Elevated c-reactive protein is associated with worse acute-phase antidepressant response in women but not men: Findings from the EMBARC Study
136. Differential prediction of antidepressant treatment response via measurement of baseline adiponectin level: findings from the CO-MED randomized clinical trial
137. Psychopharmacology and Experimental Therapeutics for Bipolar Depression
138. Exploring the Association of Sex Differences and Exposure to Maternal Smoking With Low Fetal Growth
139. Expression of immune markers in post-mortem brain subjects of major depression and suicidality
140. MultiChannel Caucus based MAC (MC2-MAC) Protocol for LOS Communication in Smart Grids
141. When Discontinuing SSRI Antidepressants Is a Challenge: A Response to Letters to the Editor
142. Irritability and Its Clinical Utility in Major Depressive Disorder: Prediction of Individual-Level Acute-Phase Outcomes Using Early Changes in Irritability and Depression Severity
143. Prediction of Acute-Phase Treatment Outcomes by Adding a Single-Item Measure of Activity Impairment to Symptom Measurement: Development and Validation of an Interactive Calculator from the STAR*D and CO-MED Trials
144. The Concise Health Risk Tracking-Self Report: Psychometrics within a placebo-controlled antidepressant trial among depressed outpatients
145. Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
146. Mini Quality of Life Enjoyment and Satisfaction Questionnaire
147. When Discontinuing SSRI Antidepressants Is a Challenge: Management Tips
148. Quality of life after response to acute-phase cognitive therapy for recurrent depression.
149. Proteomics profiling of inflammation-related biomarkers in antidepressant treatment response: Findings from the CO-MED trial
150. An electroencephalographic signature predicts antidepressant response in major depression.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.